Australis Capital Inc. (AUSA.CN)

0.0250 0.0000 (0.00%) At close: 02:54PM EST

Australis Capital Inc.

376 East Warm Springs Road
Suite 190
Las Vegas, NV 89119
United States
800 898 0648
https://www.ausa-corp.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Terrance R. Booth	CEO & Director	306.75k	N/A	1965
Dr. Jason Ronald Bradley Dyck Ph.D.	Chief Science Officer, Chairman of Scientific Advisory Board & Director	24.92k	N/A	1969
Ms. Leah S. Bailey	Chief Bus. Devel. Officer	236.98k	N/A	1957
Mr. Derrek Higgins	Chief Financial Officer	N/A	N/A	N/A
Mr. Roger Sykes	Chief Operating Officer	N/A	N/A	N/A
Mr. Brent Edwin Reuter	Sr. VP of Investor Relations & Strategy	N/A	N/A	1967
Mr. Paul E. Larsen	Gen. Counsel	N/A	N/A	N/A
Mr. Marc Lakmaaker	Sr. VP of Communications & Capital Markets	N/A	N/A	N/A
Mr. Fausto Aceituno Aceituno	Chief Marketing Officer	N/A	N/A	N/A
Thomas Larssen	Pres of ALPS	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Australis Capital Inc. operates as a cannabis company. It undertakes cannabis and non-cannabis, as well as horticulture projects in the United States, Canada, Denmark Finland, Iceland, Germany, the Netherlands, Bahrein, Kuwait, Southeast Asia, and Australia, as well as other jurisdictions. The company is headquartered in Las Vegas, Nevada.

Corporate Governance

Australis Capital Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.